UNITE IQ Trademark

Trademark Overview


On Tuesday, January 14, 2020, a trademark application was filed for UNITE IQ with the United States Patent and Trademark Office. The USPTO has given the UNITE IQ trademark a serial number of 88758052. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, June 13, 2022. This trademark is owned by MORNING LIGHT IP, LLC. The UNITE IQ trademark is filed in the Advertising, Business and Retail Services, Insurance & Financial Services, Treatment & Processing of Materials Services, and Computer & Software Services & Scientific Services categories with the following description:

Manufacturing services for others in the fields of biological products, biopharmaceutical products, regenerative medicine products, combination biologic/device products, or viral and non-viral vectors for use in gene therapy, modified gene therapy, cell therapy, tissue engineering; Manufacturing services for others in the fields of biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting

Rental of office space

Rental of office machinery and equipment

Rental of laboratory apparatus and instruments; Rental of laboratory equipment; Rental of laboratory instruments; Scientific laboratory services; Rental of laboratory facilities; Leasing of laboratories containing laboratory equipment for scientific research; Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assayi...
unite iq

General Information


Serial Number88758052
Word MarkUNITE IQ
Filing DateTuesday, January 14, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, June 13, 2022
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, September 15, 2020

Trademark Statements


Goods and ServicesManufacturing services for others in the fields of biological products, biopharmaceutical products, regenerative medicine products, combination biologic/device products, or viral and non-viral vectors for use in gene therapy, modified gene therapy, cell therapy, tissue engineering; Manufacturing services for others in the fields of biopharmaceuticals; Manufacturing services for others in the fields of mammalian cell banks, plasmids, adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; Manufacturing process consulting
Goods and ServicesRental of office space
Goods and ServicesRental of office machinery and equipment
Goods and ServicesRental of laboratory apparatus and instruments; Rental of laboratory equipment; Rental of laboratory instruments; Scientific laboratory services; Rental of laboratory facilities; Leasing of laboratories containing laboratory equipment for scientific research; Research and development services in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Consulting services in the fields of research and development for gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Research and development of new products for others; Process development services in the in the nature of research and development of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Scientific research and technical research services, namely, production of cell lines for others using lentivirus technology; Scientific research and technical research services relating to producing, assaying and purifying recombinant or manipulated lentivirus; Scientific and technical consulting services relating to producing, assaying, and purifying adenovirus, adeno-associated virus (AAV), bacteriophage, lentivirus, retroviruses and other viruses found in humans and animals; advisory services relating to research and development of gene therapy products and biopharmaceuticals; manufacturing support services for others, namely, cGMP (Current Good Manufacturing Practice) quality control testing in support of biopharmaceutical development and manufacturing; Quality control for others; Quality management services, namely, quality evaluation and analysis, quality assurance, and quality control, in the fields of gene therapy, modified gene therapy, cell therapy, tissue engineering and biopharmaceuticals; Material testing; Product quality testing; Scientific laboratory services; Scientific research

Classification Information


International Class035 - Advertising; business management; business administration; office functions.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, January 17, 2020
Primary Code035
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class036 - Insurance; financial affairs; monetary affairs; real estate affairs.
US Class Codes100, 101, 102
Class Status Code6 - Active
Class Status DateFriday, January 17, 2020
Primary Code036
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class040 - Treatment of materials.
US Class Codes100, 103, 106
Class Status Code6 - Active
Class Status DateFriday, January 17, 2020
Primary Code040
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateFriday, January 17, 2020
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameMORNING LIGHT IP, LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressRadnor, PA 19087

Party NameMORNING LIGHT IP, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressRadnor, PA 19087

Trademark Events


Event DateEvent Description
Monday, June 13, 2022ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, June 13, 2022ABANDONMENT - NO USE STATEMENT FILED
Thursday, September 16, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, September 14, 2021SOU EXTENSION 2 GRANTED
Tuesday, September 14, 2021SOU EXTENSION 2 FILED
Tuesday, September 14, 2021TEAS EXTENSION RECEIVED
Saturday, March 13, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, March 11, 2021SOU EXTENSION 1 GRANTED
Thursday, March 11, 2021SOU EXTENSION 1 FILED
Thursday, March 11, 2021TEAS EXTENSION RECEIVED
Tuesday, November 10, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, September 15, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, September 15, 2020PUBLISHED FOR OPPOSITION
Wednesday, August 26, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, August 13, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, August 13, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, August 12, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, August 12, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, June 25, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Thursday, June 25, 2020NON-FINAL ACTION E-MAILED
Thursday, June 25, 2020NON-FINAL ACTION WRITTEN
Wednesday, June 24, 2020TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 24, 2020CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 24, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, June 9, 2020ASSIGNED TO EXAMINER
Tuesday, March 17, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020NON-FINAL ACTION E-MAILED
Tuesday, March 17, 2020NON-FINAL ACTION WRITTEN
Thursday, March 12, 2020ASSIGNED TO EXAMINER
Friday, January 17, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Friday, January 17, 2020NEW APPLICATION ENTERED IN TRAM